Clinical Trials Browser

Phase 1 × Leukemia, Myeloid, Acute × ADI PEG20 × Clear all

NCT05001828 2026-01-21

Study of ADI-PEG 20, Venetoclax and Azacitidine in Acute Myeloid Leukemia

Phase 1 Active not recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT02875093 2020-03-05

Ph 1 Study of ADI-PEG 20 Plus Low Dose Cytarabine in Older Patients With AML

Phase 1 Terminated

Other hematologic neoplasm

Leukemia, Myeloid, Acute